Integrative MedicinePSK and other PolysaccharidesTreatment > Antiangiogenesis  


In Vivo 1994 Mar-Apr;8(2):247-50 (Animal Study)


Abstract

Suppression of in vivo tumor-induced angiogenesis by the protein-bound polysaccharide PSK

Kanoh T, Matsunaga K, Saito K, Fujii T

Kureha Chemical Ind. Co., Ltd., Biomedical Research Laboratories, Tokyo, Japan

The anti-angiogenic effects of an antitumor protein-bound polysaccharide, PSK, obtained from cultured mycelia of Coriolus versicolor in basidiomycetes were examined by the mouse dorsal air sac assay.
PSK suppressed the mouse hepatoma MH134-induced angiogenesis when assessed by morphological and biochemical examinations.
This finding suggested that the anti-metastatic effect of PSK is attributed to the suppression of tumor-induced angiogenesis.

PMID: 7522606 [PubMed - indexed for MEDLINE]

Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7522606&dopt=Abstract


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP